奧雅設計(300949.SZ)IPO擬發行1500萬股 每股定價54.23元
格隆匯2月5日丨奧雅設計(300949.SZ)披露首次公開發行股票並在創業板上市提示公吿,此次發行採用直接定價方式,全部股份通過網上發行,不進行網下詢價和配售。此次發行數量為1500萬股,其中網上發行數量為1500萬股,佔發行總量的100%。此次發行股份全部為新股,不轉讓老股。
此次發行價格為54.23元/股,投資者據此價格在2021年2月9日(T日)通過深交所交易系統並採用網上按市值申購方式進行申購。此次網上發行申購日為2021年2月9日(T日),網上申購時間為9:15-11:30,13:00-15:00。投資者在進行網上申購時無需繳付申購資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.